CERUS CORP Form 8-K Summary
Business Context and Reporting Period
Cerus Corporation (CERS) filed this Current Report on Form 8-K on April 17, 2026. The filing addresses Item 5.02 regarding the adoption of a new executive severance plan and the execution of participation agreements with key officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation arrangements and does not contain financial performance data.
Material Changes
On April 17, 2026, the Board adopted a new Severance Plan, superseding all prior severance arrangements for the following officers:
- Kevin D. Green (Chief Financial Officer)
- Vivek Jayaraman (Chief Operating Officer)
- Richard Benjamin, Ph.D. (Chief Medical Officer)
- Chrystal N. Jensen (Chief Legal Officer, General Counsel and Secretary)
Outlook, Risks, and Unusual Items
The new Severance Plan provides benefits upon termination without cause or resignation with good reason, particularly within 12 months of a change of control. Key terms include:
- Change of Control Termination: Participants receive 18 months of base salary (24 months for Mr. Jayaraman if serving as CEO) plus 1.5 times the annual target cash bonus (2 times for Mr. Jayaraman as CEO). Benefits also include 18 months of COBRA premiums (24 months for Mr. Jayaraman as CEO) and full accelerated vesting of equity awards.
- Non-Change of Control Termination: Mr. Green and Ms. Jensen are entitled to 12 months of base salary and 12 months of COBRA premiums. Mr. Jayaraman receives 12 months of base salary and COBRA premiums; if serving as CEO, he also receives full equity acceleration and a prorated bonus if termination occurs after September 30.
Risks/Contingencies: All benefits are contingent upon the participant providing an effective release of claims against the Company.
Investor Verification Checklist
- Review Exhibit 10.1 for the full text of the Cerus Corporation Severance Plan.
- Review Exhibit 10.2 for the specific participation agreements signed by the officers.
- Verify the potential financial impact of accelerated equity vesting and lump-sum severance payments in the event of a change of control.
- Confirm the specific definitions of "without cause" and "good reason" within the plan documents.